NCT02376972 - Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis | Biotech Hunter

Enrollment

392

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

BACTERIAL VAGINOSIS

Interventions

DRUG

RIFAXIMIN VAGINAL TABLET 25 MG

RIFAXIMIN VAGINAL TABLET 25 MG O.D./5 DAYS INTRAVAGINALLY

DRUG

RIFAXIMIN VAGINAL TABLET 100 MG

RIFAXIMIN VAGINAL TABLET 100 MG O.D./5 DAYS INTRAVAGINALLY

DRUG

PLACEBO VAGINAL TABLET

PLACEBO VAGINAL TABLET O.D./5 DAYS INTRAVAGINALLY

DRUG

METROGEL VAGINAL

METROGEL VAGINAL O.D./5 DAYS INTRAVAGINALLY

Trial Locations (1)

College of Medicine Drexel University, Philadelphia